The 2025 J.P. Morgan Healthcare Conference highlighted key predictions and emerging trends in healthcare, with a focus on the growing potential of RNA interference and cell therapies to revolutionize precision medicine. As these technologies advance, experts anticipate major breakthroughs in treating previously untreatable conditions, offering new hope for patients and reshaping the future of healthcare. Experts, including Jonathan Shoemaker, CEO of ABOUT Healthcare, also warned of significant operational challenges ahead, driven by severe staffing shortages and an aging population. Shoemaker emphasized that the healthcare sector isn’t fully prepared for these pressures and called for improved operational efficiency to address the demographic shifts and workforce gaps.
Read the full article in Drug Discovery & Development.